Both PU.1 and Nuclear Factor-κB Mediate Lipopolysaccharide-Induced HIV-1 Long Terminal Repeat Transcription in Macrophages
Abstract
We recently reported that LPS stimulation of monocytic cells leads to the activation of PU.1, a member of the Ets family of transcription factors. Phosphorylation of PU.1 by protein kinase CK2 was found to up-regulate its trans-activation function, but not its DNA binding activity. Previous studies suggested that Ets proteins could bind to NF-κB motifs at the tetrameric core sequence TTCC. In macrophages, LPS-inducible HIV-1 gene expression is mediated in part by binding of NF-κB to identical tandem binding sites located within the long terminal repeat (LTR). Thus, we performed additional studies to determine whether PU.1 also played a role in regulating HIV-1 gene expression in macrophages. Our functional studies revealed that activation of the HIV-1 LTR in LPS-stimulated cells requires both NF-κB and PU.1. Extensive mutagenesis of the HIV-1 LTR revealed that PU.1-dependent activation requires the Ets motif within the upstream NF-κB site, whereas NF-κB itself binds to the downstream site. We also found that insertion of five additional nucleotides between the NF-κB sites abolished LPS inducibility, suggesting a direct interaction between factors that bind these sites. Lastly, we found that mutation of PU.1 at serine 148, which prevents its phosphorylation by CK2, blocked its ability to activate the HIV-1 LTR in response to LPS. These effects were promoter specific because PU.1 did not affect LPS-inducible activation of a distinct NF-κB-dependent promoter. While these data do not demonstrate direct binding of PU.1 to the HIV-1 LTR, they illustrate a novel role for PU.1 in activation of the HIV-1 LTR by LPS.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745 · see citing works
An inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G. J., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,076 · see citing works
Osborn, L., Kunkel, S. L., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,642 · see citing works
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229 · see citing works
Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368 · Cited by 354 · see citing works
Baldwin, A. S., & Sharp, P. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.723 · Cited by 307 · see citing works
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 282 · cited 2× · see citing works
“Charles Van Beveren (Sidney Kimmel Cancer Center, San Diego, CA) and were previously described (18).”
BackgroundResultKornbluth, R. S., Oh, P., Munis, J. R., Cleveland, P. H., & Richman, D. D. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.3.1137 · Cited by 270 · see citing works
Majello, B., Luca, P. D., Hagen, G., et al. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.23.4914 · Cited by 230 · see citing works
Perkins, N. D., Agranoff, A. B., Pascal, E., & Nabel, G. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6570 · Cited by 229 · see citing works
Southgate, C. D., & Green, M. R. (1991) · Genes & Development · doi:10.1101/gad.5.12b.2496 · Cited by 217 · see citing works
Leonard, J. M., Parrott, C., Buckler-White, A. J., et al. (1989) · Journal of Virology · doi:10.1128/jvi.63.11.4919-4924.1989 · Cited by 211 · see citing works
Pomerantz, R. J., Feinberg, M. B., Trono, D., et al. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.1.253 · Cited by 206 · see citing works
Lin, R., Beauparlant, P., Makris, C., Meloche, S., & Hiscott, J. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1401 · Cited by 198 · see citing works
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition.
Delude, R. L., Savedra, R., Zhao, H., Thieringer, R., Yamamoto, S., Fenton, M. J., & Golenbock, D. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9288 · Cited by 178 · see citing works
Self-citationHenderson, A. J., Zou, X., & Calame, K. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5337-5344.1995 · Cited by 173 · see citing works
Bassuk, A. G., Anandappa, R. T., & Leiden, J. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3563-3573.1997 · Cited by 136 · see citing works
Casein kinase II is a selective target of HIV-1 transcriptional inhibitors
Critchfield, J. W., Coligan, J. E., Folks, T. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6110 · Cited by 136 · see citing works
Savedra, R., Delude, R. L., Ingalls, R. R., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2549 · Cited by 123 · see citing works
Self-citationC/EBP Activators Are Required for HIV-1 Replication and Proviral Induction in Monocytic Cell Lines
Henderson, A. J., Connor, R. I., & Calame, K. L. (1996) · Immunity · doi:10.1016/s1074-7613(00)80313-1 · Cited by 110 · see citing works
Spi-1/PU.1: an oncogene of the Ets family
Moreau-Gachelin, F. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90011-6 · Cited by 110 · see citing works
Lodie, T. A., Savedra, R., Golenbock, D. T., Van Beveren, C. P., Maki, R. A., & Fenton, M. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1848 · Cited by 110 · see citing works
Self-citationPU.1 Recruits a Second Nuclear Factor to a Site Important for Immunoglobulin κ 3' Enhancer Activity
Pongubala, J. M. R., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368-378.1992 · Cited by 105 · see citing works
Zeichner, S. L., Kim, J., & Alwine, J. C. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2436-2444.1991 · Cited by 103 · see citing works
Flory, E., Hoffmeyer, A., Smola, U., Rapp, U. R., & Bruder, J. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2260-2268.1996 · Cited by 88 · see citing works
Doerre, S., Sista, P. R., Sun, S., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1023 · Cited by 85 · see citing works
Bernstein, M. S., Tong-Starksen, S., & Locksley, R. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115337 · Cited by 81 · see citing works
Viglianti, G. A., & Mullins, J. I. (1988) · Journal of Virology · doi:10.1128/jvi.62.12.4523-4532.1988 · Cited by 80 · see citing works
Self-citationLowenthal, J. W., Böhnlein, E., Ballard, D. W., & Greene, W. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4468 · Cited by 68 · see citing works
Langer, S. J., & Ostrowski, M. C. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.9.3872 · Cited by 65 · see citing works
Hunninghake, G. W., Monks, B. G., Geist, L. J., Monick, M. M., Monroy, M. A., Stinski, M. F., Webb, A. C., Dayer, J. M., Auron, P. E., & Fenton, M. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3439 · Cited by 59 · see citing works
Self-citationRegulation of HIV expression by viral genes and cytokines
Vicenzi, E., & Poli, G. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.3.328 · Cited by 41 · see citing works
ETS Family Proteins Activate Transcription from HIV-1 Long Terminal Repeat
Seth, A. K., Hodge, D. R., Thompson, D. M., Robinson, L., Panayiotakis, A., Watson, D. K., & Papas, T. S. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1017 · Cited by 41 · see citing works
Buras, J. A., Monks, B. G., & Fenton, M. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.9.4444 · Cited by 39 · see citing works
Self-citationThe PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter
Carvalho, M. D. G., & Derse, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3885-3890.1993 · Cited by 39 · see citing works
Buras, J. A., Reenstra, W. R., & Fenton, M. J. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00018-a · Cited by 34 · see citing works
Self-citationPhares, W., Franza, B. R., & Herr, W. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7490-7498.1992 · Cited by 28 · see citing works
Gaynor, R. B., Kuwabara, M. D., Wu, F. K., et al. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9406 · Cited by 27 · see citing works
Conant, K. E., Atwood, W. J., Traub, R. G., et al. (1994) · Virology · doi:10.1006/viro.1994.1685 · Cited by 22 · see citing works
Flagged first, then by citations
Research works printed but not linked: 38
- 1990, J. Exp. Med., 253
- 1994, J. Leukocyte Biol., 328
- 1987, Nature, 711
- 1989, Proc. Natl. Acad. Sci. USA, 2336
- 1994, Nucleic Acids Res., 4914
- 1994, Mol. Cell. Biol., 6570
- 1995, J. Virol., 5337
- 1996, Immunity, 91
- 1994, Annu. Rev. Immunol., 141
- 1991, J. Virol., 2436
- 1992, J. Virol., 7490
- 1994, Virology, 586
- 1993, AIDS Res. Hum. Retroviruses, 1017
- 1997, J. Virol., 3563
- 1996, J. Virol., 2260
- 1994, Biochim. Biophys. Acta, 149
- 1992, Mol. Cell. Biol., 368
- 1993, Science, 1662
- 1995, Mol. Immunol., 541
- 1997, J. Immunol., 1848
- 1995, Proc. Natl. Acad. Sci. USA, 9288
- 1996, Mol. Cell. Biol., 1401
- 1991, Genes Dev., 2496
- 1989, J. Virol., 4919
- 1988, Proc. Natl. Acad. Sci. USA, 4468
- 1988, J. Virol., 4523
- 1989, J. Biol. Chem., 8222
- 1988, Mol. Cell. Biol., 3872
- 1994, J. Immunol., 4444
- 1996, J. Immunol., 2549
- 1988, Proc. Natl. Acad. Sci. USA, 9406
- 1993, Proc. Natl. Acad. Sci. USA, 1023
- 1988, Proc. Natl. Acad. Sci. USA, 723
- 1992, Mol. Cell. Biol., 3439
- 1997, Proc. Natl. Acad. Sci. USA, 6110
- 1993, J. Virol., 3885
- 1989, J. Exp. Med., 1137
- 1991, J. Clin. Invest., 540
Cited by
Sorted by citations
c-Myc Is a Critical Target for C/EBPα in Granulopoiesis
Johansen, L. M., Iwama, A., Lodie, T. A., Sasaki, K., Felsher, D. W., Golub, T. R., & Tenen, D. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.11.3789-3806.2001 · Cited by 263 · see citing works
“described previously (41) using an E2F binding site oligonucleotide (CTCAGA”
BackgroundMethodSelf-citationPhosphorothioate Backbone Modification Modulates Macrophage Activation by CpG DNA
Sester, D. P., Naik, S. H., Beasley, S. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4165 · Cited by 122 · see citing works
Host hindrance to HIV-1 replication in monocytes and macrophages
Bergamaschi, A., & Pancino, G. (2010) · Retrovirology · doi:10.1186/1742-4690-7-31 · Cited by 105 · see citing works
“1, which allows its interaction with the LTR promoter [143] and with the NFκB transcription factor bound to the downstream binding site.”
BackgroundPiazza, F., Manni, S., Ruzzene, M., Pinna, L. A., Gurrieri, C., & Semenzato, G. (2012) · Leukemia · doi:10.1038/leu.2011.385 · Cited by 102 · see citing works
Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells
Alvarez-Carbonell, D., García‐Mesa, Y., Milne, S., Das, B., Dobrowolski, C. N., Rojas, R. E., & Karn, J. (2017) · Retrovirology · doi:10.1186/s12977-017-0335-8 · Cited by 97 · see citing works
Effects of Notch Signaling on Regulation of Myeloid Cell Differentiation in Cancer
Cheng, P., Kumar, V., Liu, H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1686 · Cited by 98 · see citing works
“1 (42), and Etsfamily transcription factors Sp1 and Sp3 (43).”
Pipitone, N., Sinha, M., Theodoridis, E., Goulding, N. J., Hall, M. D., Lanchbury, J. S. S., Corrigall, V., Panayi, G. S., & Pitzalis, C. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7 · Cited by 19 · see citing works
Marecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87 · see citing works
Self-citationTREM‐1 expression in macrophages is regulated at transcriptional level by NF‐κB and PU.1
Zeng, H., Ornatowska, M., Joo, M., & Sadikot, R. T. (2007) · European Journal of Immunology · doi:10.1002/eji.200737270 · Cited by 84 · see citing works
Stütz, A. M., & Woisetschläger, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4383 · Cited by 93 · see citing works
“Interestingly, the architecture of the HIV-1 long-terminal repeat promoter/enhancer is reminiscent to the one of the IgE germline promoter (47).”
BackgroundWalton, M. R., Gibbons, H., MacGibbon, G. A., Sirimanne, E., Saura, J., Gluckman, P. D., & Dragunow, M. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00262-3 · Cited by 73 · see citing works
“…factor (CSF-1) receptor), CD11b, FcgR1b, HIV-1 long terminal repeat and CD18 (Rosmarin et al., PU.1 is a member of the Ets transcription factor family 1992; Pahl et al., 1993; Perez et al., 1994; Zhang et al., found predominantly in macrophages, mast cells, B cells, 1994; Lodie et al., 1998).”
BackgroundBacterial Lipopolysaccharide Activates HIV Long Terminal Repeat Through Toll-Like Receptor 4
Equils, O., Faure, E., Thomas, L. S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2342 · Cited by 72 · see citing works
“PI3 kinase is also involved in TNF-a mediated activation of NFkB-dependent genes; the inhibition of PI3 kinase activity by wortmannin or LY294002 has been reported to greatly potentiate TNFa-induced apoptosis (48).”
BackgroundReview: The Role of IRF-4 in Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452737 · Cited by 67 · see citing works
“(70,71,85) Similarly, mutation of serine 148 to alanine resulted in the loss of LPS-induced transcriptional activation, suggesting that phosphorylation of serine 148 is required for inducible transcriptional activation by LPS. Phos-MARECKI phorylation of other serine residues (41, 45, 132, and 133)…”
Self-citationMechanisms of HIV Transcriptional Regulation and Their Contribution to Latency
Lester, G. M. S., & Henderson, A. J. (2012) · Molecular Biology International · doi:10.1155/2012/614120 · Cited by 55 · see citing works
“1 [40, 41], and TCF/LEF-1 [42, 43] to cite a select few.”
BackgroundThe Interleukin-1β Gene Is Transcribed from a Poised Promoter Architecture in Monocytes
Liang, M. D., Zhang, Y., McDevit, D. C., Marecki, S., & Nikolajczyk, B. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510700200 · Cited by 55 · see citing works
Krehan, A., Ansuini, H., Böcher, O., Grein, S., Wirkner, U., & Pyerin, W. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909736199 · Cited by 53 · see citing works
Cocaine Enhances HIV-1 Infectivity in Monocyte Derived Dendritic Cells by Suppressing microRNA-155
Napuri, J., Pilakka‐Kanthikeel, S., Raymond, A., Agudelo, M., Yndart, A., Saxena, S. K., & Nair, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083682 · Cited by 49 · see citing works
“NF-kB subunits within the LTR [26].”
Dekoninck, A., Calomme, C., Nizet, S., de Launoit, Y., Burny, A., Ghysdael, J., & Lint, C. M. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206392 · Cited by 34 · see citing works
Smith, M. F., Carl, V. S., Lodie, T. A., & Fenton, M. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24272 · Cited by 35 · see citing works
Self-citationNF-κB and HIV: Linking viral and immune activation
Rabson, A. B., & Lin, H.-C. (2000) · Advances in pharmacology · doi:10.1016/s1054-3589(00)48006-3 · Cited by 30 · see citing works
Nordone, S. K., Ignacio, G. A., Su, L., et al. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0033 · Cited by 29 · see citing works
“17,36 Along these same lines, we observed that TLR9 activation by B class CpG ODN resulted in virus production despite relatively minor NF-(cid:2) B activation.”
Simard, S., Maurais, É., Gilbert, C., & Tremblay, M. J. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.007 · Cited by 27 · see citing works
Cellular specificity of HIV-1 replication can be controlled by LTR sequences
Reed-Inderbitzin, E., & Maury, W. (2003) · Virology · doi:10.1016/s0042-6822(03)00508-7 · Cited by 26 · see citing works
Hanley, T. M., Kiefer, H. L. B., Schnitzler, A. C., Marcello, J. E., & Viglianti, G. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2819-2830.2004 · Cited by 26 · see citing works
“1 (37) to the LTR; by IL-1 /IL-6, which stimulate HIV-1 expression through NF- B (42), NF-IL-6 (60), and undefined transcriptional and posttranscriptional mechanisms (46); and by TSA, which induces histone hyperacetylation and chromatin remodeling (63).”
BackgroundSelf-citationThe Igκ3′ Enhancer Is Activated by Gradients of Chromatin Accessibility and Protein Association
McDevit, D. C., Perkins, L., Atchison, M. L., & Nikolajczyk, B. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2834 · Cited by 26 · see citing works
“1 function as a transcriptional activator (13, 44).”
BackgroundShocking HIV-1 with immunomodulatory latency reversing agents
Kula, A., Rodari, A., Darcis, G., & Lint, C. M. V. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101478 · Cited by 25 · see citing works
Lai, S., Wang, G., Wang, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6011 · Cited by 19 · see citing works
“For this purpose, we constructed a luciferase reporter under the control of the major NF-κB transcription element [26] Figure 1: Over-expression of p55PIK in GIST882IR cells and IMA-resistance-GIST samples and increased expression of p55PIK led to the IMA-resistance in GIST882 cells.”
Involvement of PKA, PKC, and Ca2+ in LPS-activated expression of the chicken lysozyme gene
Regenhard, P., Goethe, R., & Phi‐van, L. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.651 · Cited by 19 · see citing works
“1 is enhanced by phosphorylation at serine(148) following LPS stimulation [45].”
BackgroundMouzaki, Α., Doucet, A., Mavroidis, E., et al. (2000) · Molecular Medicine · doi:10.1007/bf03401782 · Cited by 16 · see citing works
Kao, S., Miyagi, E., Mallorson, R., Saito, H., Sukegawa, S., Mukherji, A., Mateja, A., Ferhadian, D., Fabryova, H., Clouse, K., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00652-22 · Cited by 8 · see citing works
“1 on the HIV-1 LTR as opposed to the inhibitory effect reported here (44).”
BackgroundHIV Expression in Infected T Cell Clones
Rausch, J. W., Parvez, S., Pathak, S., Capoferri, A. A., & Kearney, M. F. (2024) · Viruses · doi:10.3390/v16010108 · Cited by 9 · see citing works
“The HIV-1 enhancer can bind other transcription factors as well, including Ets-1 [108] and E2F-1 [109], to inhibit or augment the stimulatory activity of NF-κ B [110].”
BackgroundAgosto, L. M., Hirnet, J. B., Michaels, D., et al. (2016) · Virology · doi:10.1016/j.virol.2016.09.007 · Cited by 7 · see citing works
Self-citationLung CD4 Lymphocytes Predict Survival in Asymptomatic HIV Infection
Wewers, M. D., Lemeshow, S. A., Lehman, A., et al. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2262 · Cited by 5 · see citing works
Brg1 regulates fibroblast-myofibroblast transition to promote renal fibrosisPreprint
Wu, X., Luo, Y., Kang, A., Ni, J., Kong, M., & Zhang, T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.22.572996
- Authors
- Lodie, T. A., Reiner, M., Coniglio, S., Viglianti, G., & Fenton, M. J.
- Affiliations
- Boston University (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-07-01
- Volume
- 161
- Issue
- 1
- Pages
- 268-276
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W4313341474
- Semantic Scholar
- d127728ff4d26600e5afc14aaba6fb2218b472e3
- Cited by
- 36
- References
- 38
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 3 · 2012: 2
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- PU.1, NF-κB, HIV-1 long terminal repeat, lipopolysaccharide, macrophages, ETS transcription factors, CK2 phosphorylation, transcriptional activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review